Cancer Stories
Didn't see your exact story?
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
Cancer Stories
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
Nikoo’s first experience with invasive lobular carcinoma began in 2003, when her general practitioner felt hard tissue in her right breast even though she had recently had a clear mammogram. Ultrasound and biopsy found a 0.9 cm lobular breast cancer. She had a lumpectomy, radiation, and 5 years of tamoxifen, and she was told the cancer had been found early. Nineteen years later, new digestive symptoms appeared suddenly. Nikoo developed food sensitivity, nausea, bloating, and weight loss. A prior endoscopy and colonoscopy had been clear, and antacids did not help. After a second opinion, ultrasound and CT showed soft tissue thickening near the distal right ureter, severe hydroureteronephrosis, multiple sclerotic bone findings concerning for metastatic disease, and small-volume ascites. A ureter and bladder biopsy showed inflammation, but the symptoms continued. A gynecological oncologist performed a scope of her lower abdomen, and Nikoo learned that her old breast cancer had metastasized after 19 years. The metastatic lobular breast cancer involved the peritoneum, ascites, and possible bone. Biomarker results were ER-positive, PR-positive, and HER2-negative. Nikoo turned to metastatic ILC support groups and LBCA resources to regain knowledge and control. The experience strengthened her advocacy for careful second opinions and persistence.
This is a lay summary of an account first published by Lobular Breast Cancer Alliance. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer